Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor ( G-CSF ) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer.